Learning Objectives

■ Identify one’s knowledge regarding advancements in migraine therapies over the last 3 years

■ Compare clinical efficacy, benefits, and side effects of newer pharmacotherapies to their predecessors

■ Apply this knowledge towards clinical decision making to help make the best treatment choice tailored to individual patient needs

■ Survey evolving non-pharmacological modalities and their utility in migraine management



Click here to complete today’s evaluation: https://ce.icep.wisc.edu/neurology-grand-rounds-20-22-eval-15135

Session date: 
11/08/2021 - 4:00pm to 5:00pm CST
Medical Foundation Centennial Bldg, Room #1220
1685 Highland Ave
Madison, WI 53705
United States
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™

Please login or register to take this course.
Discloser List CME Internal Report